Why under-40s will be offered alternative to Oxford-AstraZeneca vaccine
Experts say potential blood clot risk vs. benefits of the Covid jab is ‘more finely balanced’ for younger adults
Follow Our Network On LinkedIn: Follow link
Experts say potential blood clot risk vs. benefits of the Covid jab is ‘more finely balanced’ for younger adults
